Clinical isolate of Citrobacter freundii highly resistant to new quinolones

Antimicrob Agents Chemother. 1988 Jun;32(6):922-4. doi: 10.1128/AAC.32.6.922.

Abstract

About 30% of 150 recent clinical isolates of Citrobacter freundii were resistant to greater than or equal to 3.13 micrograms of norfloxacin and ofloxacin per ml. Study of one quinolone-resistant strain for which the norfloxacin MIC was 100 micrograms/ml suggested that resistance was associated with both an altered A subunit of DNA gyrase and reduction in drug uptake accompanied by a decrease in an outer membrane protein.

MeSH terms

  • Bacterial Outer Membrane Proteins / metabolism
  • Citrobacter / drug effects*
  • Citrobacter / genetics
  • DNA Topoisomerases, Type II / metabolism
  • Drug Resistance, Microbial
  • Electrophoresis, Polyacrylamide Gel
  • Quinolines / pharmacology*

Substances

  • Bacterial Outer Membrane Proteins
  • Quinolines
  • DNA Topoisomerases, Type II